InChI=1S/C48H75N5O8S/c1- 14- 29(3) 41- 46(58) 53- 21- 15- 16- 38(53) 47(59) 61- 40(31(5) 26- 48(8,9) 10) 23- 28(2) 22- 39(54) 32(6) 43- 49- 35(27- 62- 43) 24- 30(4) 42(55) 50- 37(25- 34- 17- 19- 36(60- 13) 20- 18- 34) 45(57) 51(11) 33(7) 44(56) 52(41) 12/h17- 20,24,28- 29,31- 33,35,37- 41,54H,14- 16,21- 23,25- 27H2,1- 13H3,(H,50,55) /b30- 24+/t28- ,29- ,31- ,32- ,33- ,35- ,37- ,38- ,39- ,40- ,41- /m0/s1 |
OFUDGDJEKOUEKG-MBNNSLKJSA-N |
CC[C@H] (C) [C@@H] 1N(C) C(=O) [C@H] (C) N(C) C(=O) [C@H] (Cc2ccc(OC) cc2) NC(=O) \C(C) =C\[C@H] 2CSC(=N2) [C@@H] (C) [C@@H] (O) C[C@H] (C) C[C@H] (OC(=O) [C@@H] 2CCCN2C1=O) [C@@H] (C) CC(C) (C) C |
|
Lyngbya majuscula
(NCBI:txid158786)
|
See:
PubMed
|
Lyngbya sordida
(NCBI:txid748015)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(3S,5S,7S,8S,12S,13E,17S,20S,23S,28aS)- 23- [(2S)- butan- 2- yl]- 3- [(2S)- 4,4- dimethylpentan- 2- yl]- 7- hydroxy- 17- (4- methoxybenzyl)- 5,8,14,19,20,22- hexamethyl- 3,4,5,6,7,8,11,12,16,17,19,20,22,23,26,27,28,28a- octadecahydro- 1H- 12,9- (azeno)pyrrolo[2,1- c][1,19,4,7,10,13]oxathiatetraazacyclohexacosine- 1,15,18,21,24- pentone
|
18840921
|
Reaxys Registry Number
|
Reaxys
|
18444683
|
PubMed citation
|
Europe PMC
|
23057680
|
PubMed citation
|
Europe PMC
|
|